“…The current estimation of the overall risk of pancreatic cancer among diabetics is consistent with the up to 2-fold increase in risk reported by other investigators (5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22) and supports previous work that has identified an inverse temporal relationship between diabetes and pancreatic cancer with cancer-associated risk decreasing with increasing duration of diabetes (5, 13, 16, 29-32) Because of rapid case ascertainment, use of in-person interviews rather than proxy, and population-based sampling, our observations are robust and lend further support to the hypothesis that diabetes may often be a consequence rather than a cause of pancreatic cancer, or an early marker of the disease (6, 10, 16, 20-23, 33, 34). Our results extend the results of prior case-control and cohort studies by assessing the association between medication use for diabetes and pancreatic cancer risk.…”